Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis

Human dihydroorotate dehydrogenase is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis, psoriasis...